Nuveen
IDYA icon

Nuveen’s IDEAYA Biosciences IDYA Stock Holding History

Nuveen’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.9M Buy
640,257
+191,984
+43% +$5.88M 0.01% 1152
2026
Q1 		$14.9M Buy
448,273
+74,266
+20% +$2.49M ﹤0.01% 1312
2025
Q4 		$12.9M Buy
374,007
+165,248
+79% +$5.27M ﹤0.01% 1407
2025
Q3 		$5.68M Sell
208,759
-8,561
-4% -$207K ﹤0.01% 1845
2025
Q2 		$4.57M Sell
217,320
-69,994
-24% -$1.34M ﹤0.01% 1927
2025
Q1 		$4.71M Buy
287,314
+18,199
+7% +$388K ﹤0.01% 1951
2024
Q4 		$6.92M Buy
269,115
+2,779
+1% +$78.7K ﹤0.01% 1811
2024
Q3 		$8.44M Buy
266,336
+11,043
+4% +$419K ﹤0.01% 1721
2024
Q2 		$8.96M Sell
255,293
-105,789
-29% -$4.19M ﹤0.01% 1640
2024
Q1 		$15.8M Sell
361,082
-17,831
-5% -$767K ﹤0.01% 1315
2023
Q4 		$13.5M Sell
378,913
-167,347
-31% -$4.99M ﹤0.01% 1397
2023
Q3 		$14.7M Sell
546,260
-21,228
-4% -$538K 0.01% 1238
2023
Q2 		$13.3M Buy
567,488
+328,581
+138% +$6.76M ﹤0.01% 1332
2023
Q1 		$3.28M Sell
238,907
-180,082
-43% -$3M ﹤0.01% 2120
2022
Q4 		$7.61M Buy
418,989
+152,173
+57% +$2.56M ﹤0.01% 1670
2022
Q3 		$3.98M Buy
266,816
+21,010
+9% +$273K ﹤0.01% 2032
2022
Q2 		$3.39M Buy
245,806
+96,199
+64% +$1.07M ﹤0.01% 2173
2022
Q1 		$1.74M Buy
149,607
+32,756
+28% +$483K ﹤0.01% 2569
2021
Q4 		$2.48M Sell
116,851
-8,012
-6% -$186K ﹤0.01% 2468
2021
Q3 		$3.35M Buy
124,863
+9,025
+8% +$211K ﹤0.01% 2427
2021
Q2 		$2.43M Buy
115,838
+37,130
+47% +$763K ﹤0.01% 2611
2021
Q1 		$1.85M Sell
78,708
-3,800
-5% -$73.4K ﹤0.01% 2657
2020
Q4 		$1.16M Buy
82,508
+16,130
+24% +$219K ﹤0.01% 2750
2020
Q3 		$834K Buy
66,378
+13,247
+25% +$164K ﹤0.01% 2762
2020
Q2 		$755K Buy
+53,131
New +$419K ﹤0.01% 2740

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Nuveen's IDYA Position: Q2 2026 in Review

Nuveen increased its IDEAYA Biosciences (IDYA) stake by 43% in Q2 2026, buying an estimated $5.88M and bringing the position to 640,257 shares worth $23.9M. The position accounts for 0.01% of the portfolio, ranked #1152.

Nuveen first reported a position in IDYA in Q2 2020 and has held it in 25 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Nuveen held 640,257 shares of IDEAYA Biosciences worth $23.9M as of Q2 2026.
  • Nuveen bought 191,984 IDEAYA Biosciences shares in Q2 2026, an estimated $5.88M.
  • IDEAYA Biosciences made up 0.01% of Nuveen's portfolio in Q2 2026, its #1152 holding.
  • Nuveen first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 25 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.